Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ALK fusion and its association with other driver gene mutations in Finnish non-small cell lung cancer patients.

Genes, chromosomes & cancer - 1 Nov 2014

Tuononen Katja, Kero Mia, Mäki-Nevala Satu, Sarhadi Virinder Kaur, Tikkanen Milja, Wirtanen Tiina, Rönty Mikko, Knuuttila Aija, Knuutila Sakari

Abstract excerpt

Screening of anaplastic lymphoma tyrosine kinase (ALK) gene fusions in non-small cell lung cancer (NSCLC) patients enables the identification of the patients likely to benefit from ALK-targeted therapy. Our aim was to assess the prevalence of ALK fusion in Finnish NSCLC patients, which has not been reported earlier, and to study the presence of ALK fusion in relation to clinicopathological characteristics and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anaplastic Lymphoma Kinase
Share to beta Catenin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Class I Phosphatidylinositol 3-Kinases

Share to Finland

Share to Gene Fusion

Share to Phosphatidylinositol 3-Kinases

Share to Proto-Oncogene Proteins c-met

Share to Receptor Protein-Tyrosine Kinases

Source

Identifiers

PMID: 24942490
DOI: 10.1002/gcc.22198

Genes

ALK
MET
CTNNB1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ALK fusion and its association with other driver gene mutations in Finnish non-small cell lung cancer patients.PMID 24942490Read ↗

Prevalence and clinicopathological characteristics of ALK fusion subtypes in lung adenocarcinomas from Chinese populations.Semantic proximity Read ↗

Clinicopathological features and diagnostic methods of ALK fusion‑positive non‑small cell lung cancer in Korea.Semantic proximity Read ↗

ALK‐ rearrangement in non‐small‐cell lung cancer (NSCLC)Semantic proximity Read ↗

Next generation sequencing detection in archival surgically resected lung adenocarcinoma specimens harbouring the anaplastic lymphoma kinase fusion protein.Semantic proximity Read ↗

Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese populationSemantic proximity Read ↗

Molecular and clinical analysis of Chinese patients with anaplastic lymphoma kinase ( ALK )‐rearranged non‐small cell lung cancerSemantic proximity Read ↗

The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS.Semantic proximity Read ↗

[Clinicopathological features of patients with RET fusion-positive non-small cell lung cancer].Semantic proximity Read ↗

Catalog of 5’ Fusion Partners in ALK-positive NSCLC Circa 2020Semantic proximity Read ↗

Emerging oncogenic fusions other than ALK, ROS1, RET, and NTRK in NSCLC and the role of fusions as resistance mechanisms to targeted therapySemantic proximity Read ↗

A Screening Method for the ALK Fusion Gene in NSCLCSemantic proximity Read ↗

Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.